We are monitoring the impact of COVID-19 on Europe Viscosupplementation Market Get in touch with us for detailed analysis Know More
Pulished Date May, 2021
ID: 11532
Share on
Share on

Europe Viscosupplementation Market Research Report - Segmented By Product Type, End-User and Country (United Kingdom, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands and Rest of Europe) - Industry Share, Trends & Growth Forecast (2021 to 2026)

Pulished: May, 2021
ID: 11532
Pages: 90

Europe Viscosupplementation Market Size (2021 to 2026)

The size of the Europe Viscosupplementation Market is forecasted to worth USD 312 million by 2026, growing at a CAGR of 4.98% between 2021 to 2026.

The European Viscosupplementation Market is expected to be driven by the factors growing demand for nonsurgical treatments for osteoarthritis and advancements in the development of hyaluronic. The rising prevalence of osteoarthritis and a well-established healthcare system in Europe are driving up demand for viscosupplementation. The favorable reimbursement programs in the European region are likely to uplift the market growth.

Recent advances in product pipeline R&D in the developed countries like Germany and UK have created new opportunities for the viscosupplementation market to grow. The prevalence of lifestyle-related disorders and advances in the production of hyaluronic acid-based therapies are expected to fuel growth. Viscosupplements available in the market have shown clinical efficacy and are proven to be the most effective treatment for knee osteoarthritis. The levels of HA in the joints of patients with OA are lower than average. Injecting HA through muscles lubricates them, allowing them to glide easily alongside one another.

Viscosupplementation helps arthritic joints move more freely and comfortably. It is often recommended where other nonsurgical treatment methods have failed to provide satisfactory results. Intra-articular injections of hyaluronic acid have proven to be one of the more common treatments for symptomatic knee osteoarthritis; hence it is expected to drive the market growth.

Lack of inefficiency and safety of product impede the market growth. However, the high price of hyaluronic acid treatment is expected to be one of the growth restraining factors to the European viscosupplementation market. 

Impact of COVID-19 on the Europe viscosupplementation market:

The sudden emergence of the covid-19 pandemic has been affected the regional economy. The different sectors of the economy have been affected by the pandemic but except in the case of some pharmaceutical companies. 

The outbreak of pandemic had negatively impacted the European viscosupplementation market during the first half of 2020. The surge in the COVID-19 cases had led to the nationwide lockdown. Europe also implemented the lockdown and imposed a ban on transportation to restrict the virus transmission. Furthermore, to deal with the Covid-19 epidemic, governments all over Europe are advocating on behalf of healthcare professionals. As a result of this factor, the market growth could slow. With emerging and developing economies recovering from the COVID-19 pandemic, the viscosupplementation market could gain momentum in the first quarter of 2021. 

This market research report on the European viscosupplementation market has been segmented and sub-segmented into the following categories.

By Product:

  • Single Injection
  • Three Injection
  • Five Injection

By End-Use:

  • Hospitals
  • Orthopedic Clinic/ Ambulatory Surgical Centers (ASCs)

By Country:

  • UK
  • France
  • Spain
  • Germany
  • Italy
  • Russia
  • Sweden
  • Denmark
  • Switzerland
  • Netherlands
  • Turkey
  • Czech Republic
  • Rest of Europe

Geographically, the European viscosupplementation market is forecasted to account for a significant chunk of share in the global market during the forecast period. The increasing prevalence of OA is expected to propel the growth of the European viscosupplementation market over the forecast period. 

According to the report, ‘Prevalence and progression of hip and knee osteoarthritis according to American College of Rheumatology guidelines in the CHECK cohort,' published in BMC Arthritis Research & Therapy in January 2019, 63 percent of participants in the Netherlands had hip OA, and 92 percent of those with knee problems had knee OA. Germany, UK, France, Spain, and Italy are the growth contributors in this region. 

The German viscosupplementation market is anticipated to be one of the largest contributors in Europe's Viscosupplementation market over the forecast period. The market growth is attributed to the advanced healthcare infrastructure, demand for nonsurgical procedures, and growing awareness regarding the effectiveness of Viscosupplementation. Germany held the highest market shareholder and a major contributor to the European regional market growth. 

The United Kingdom viscosupplementation market is estimated to be another lucrative regional market in the European region due to the growing geriatric population. 


Sanofi S.A., Zimmer Biomet Holdings Inc., Bioventus LLC, Anika Therapeutics Inc., Fidia Farmaceutici S.p.A., Ferring B.V., Seikagaku Corporation, Chungai Pharmaceutical Co., Ltd., OrthogenRx Inc., and Mylan N.V. are some of the promising companies dominating the European viscosupplementation market.

  1. Introduction
    1. Market Definition
    2. Study Deliverables
    3. Base Currency, Base Year and Forecast Periods
    4. General Study Assumptions
  2. Research Methodology
    1. Introduction
    2. Research Phases
        1. Secondary Research
        2. Primary Research
        3. Econometric Modelling
        4. Expert Validation
    3. Analysis Design
    4. Study Timeline
  3. Overview
    1. Executive Summary
    2. Key Inferences
    3. New Developments
  4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
    1. Market Drivers
    2. Market Restraints
    3. Key Challenges
    4. Current Opportunities in the Market
  5. Market Segmentation
    1. By Product
      1. Single Injection
      2. Three Injection
      3. Five Injection
      4. Y-o-Y Growth Analysis, By Product
      5. Market Attractiveness Analysis, By Product
      6. Market Share Analysis, By Product
    2. By End-User
      1. Hospitals
      2. Orthopedic Clinic/ Ambulatory Surgical Centers (ASCs)
      3. Y-o-Y Growth Analysis, By End-User
      4. Market Attractiveness Analysis, By End-User
      5. Market Share Analysis, By End-User
  6. Geographical Analysis
    1. Introduction    
      1. Regional Trends   
      2. Impact Analysis    
      3. Y-o-Y Growth Analysis        
        1. By Geographical Area
        2. By Product
        3. By Distribution Channel
      4. Market Attractiveness Analysis      
        1. By Geographical Area
        2. By Product
        3. By Distribution Channel
      5.      Market Share Analysis   
        1. By Geographical Area
        2. By Product
        3. By Distribution Channel
    2. Europe
      1. Introduction
      2. UK
      3. France
      4. Spain
      5. Germany
      6. Italy
  7. Strategic Analysis
    1. PESTLE analysis
      1. Political
      2. Economic
      3. Social
      4. Technological
      5. Legal
      6. Environmental
    2. Porter’s Five analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Consumers
      3. Threat of New Entrants
      4. Threat of Substitute Products and Services
      5. Competitive Rivalry within the Industry
  8. Market Leaders' Analysis
    1. Sanofi S.A.
      1. Overview
      2. Product Analysis
      3. Strategic Evaluation and Operations
      4. Financial analysis
      5. Legal issues
      6. Recent Developments
      7. SWOT analysis
      8. Analyst View
    2. Zimmer Biomet Holdings Inc.
    3. Bioventus LLC
    4. Anika Therapeutics Inc.
    5. Fidia Farmaceutici S.p.A.
    6. Ferring B.V.
    7. Seikagaku Corporation
    8. Chungai Pharmaceutical Co., Ltd.
    9. OrthogenRx Inc.
    10. Mylan N.V
  9. Competitive Landscape
    1. Market share analysis
    2. Merger and Acquisition Analysis
    3. Agreements, Collaborations and Joint Ventures
    4. New Product Launches
  10. Market Outlook and Investment Opportunities
  11. Appendix
    1. List of Tables
    2. List of Figures 
  • Regional, and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped.
  • Segment-level analysis in terms of product and end-user along with market size forecasts and estimations to detect key areas of industry growth in detail.
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics.
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis.
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development.
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment.
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies.
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions.
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market.
  1. Europe Viscosupplementation Market, By Product, From 2021 to 2026 (USD Million)
  2. Europe Single Injection Market, By Region, From 2021 to 2026 (USD Million)
  3. Europe Three Injection Market, By Region, From 2021 to 2026 (USD Million)
  4. Europe Five Injection Market, By Region, From 2021 to 2026 (USD Million)
  5. Europe Viscosupplementation Market, By End-User, From 2021 to 2026 (USD Million)
  6. Europe Hospitals Market, By Region, From 2021 to 2026 (USD Million)
  7. Europe Orthopedic Clinic/ Ambulatory Surgical Centres (ASCs) Market, By Region, From 2021 to 2026 (USD Million)
  8. U.K. Viscosupplementation Market, By Product, From 2021 to 2026 (USD Million)
  9. U.K. Viscosupplementation Market, By End-User, From 2021 to 2026 (USD Million)
  10. Germany Viscosupplementation Market, By Product, From 2021 to 2026 (USD Million)
  11. Germany Viscosupplementation Market, By End-User, From 2021 to 2026 (USD Million)
  12. France Viscosupplementation Market, By Product, From 2021 to 2026 (USD Million)
  13. France Viscosupplementation Market, By End-User, From 2021 to 2026 (USD Million)
  14. Italy Viscosupplementation Market, By Product, From 2021 to 2026 (USD Million)
  15. Italy Viscosupplementation Market, By End-User, From 2021 to 2026 (USD Million)
  16. Spain Viscosupplementation Market, By Product, From 2021 to 2026 (USD Million)
  17. Spain Viscosupplementation Market, By End-User, From 2021 to 2026 (USD Million)

Please wait. . . . Your request is being processed

Related Reports


$ 1234 3335

Click for Request Sample